Myocardial contrast agents: Recent advances and future directions
- 31 August 2001
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 44 (1), 33-44
- https://doi.org/10.1053/pcad.2001.26438
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Clinical Experience with SonoVue in Myocardial Perfusion ImagingEchocardiography, 2000
- Ultrasound-Mediated Destruction of Contrast AgentsInvestigative Radiology, 1997
- Phase I Clinical Trials of MRX-115Investigative Radiology, 1997
- Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubblesAmerican Heart Journal, 1996
- Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injectionJournal of the American College of Cardiology, 1996
- Improved myocardial contrast with second harmonic transient ultrasound response imaging in humans using intravenous perfluorocarbon-exposed sonicated dextrose albuminJournal of the American College of Cardiology, 1996
- Acoustic quantification: a new tool for diagnostic echocardiographyCurrent Opinion in Cardiology, 1996
- Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemiaJournal of the American College of Cardiology, 1995
- Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agentsJournal of the American College of Cardiology, 1984
- Identification of Ultrasound Echoes from the Left Ventricle by Use of Intracardiac Injections of Indocyanine GreenCirculation, 1970